Inflammation

A recent study in The American Journal of Clinical Dermatology led by Igor Snast, MD, sought to evaluate the efficacy and safety of biologic agents in the treatment of atopic dermatitis (AD). The results of the study showed that in particular, dupilumab stood out.

A meta-analysis finds a connection between atopic dermatitis and occupational hand eczema.

Dupilumab's effectiveness is due to the monoclonal antibody's ability to rapidly reduce inflammation.